コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 tial component of care for all people on the autism spectrum and should be integrated into clinical p
3 y expressed in the brain and associated with autism spectrum (ASD) and attention deficit hyperactivit
4 xplain (1) evidence regarding a key role for autism spectrum cognition in human technology; (2) trade
5 with four major neuropsychiatric disorders: autism spectrum condition (ASC), bipolar disorder (BD),
6 development and behavior in 96 children with autism spectrum disorder (ASD) [45 with neurodevelopment
9 lied to neurodevelopmental disorders such as autism spectrum disorder (ASD) and attention deficit hyp
10 s investigated neuroradiological findings in autism spectrum disorder (ASD) and attention-deficit hyp
11 isorders and neurogenetic syndromes, such as autism spectrum disorder (ASD) and Dravet, Fragile X, Pr
13 nitial link between DIP2A gene variations in autism spectrum disorder (ASD) and highlight the contrib
15 AP1 have been identified in individuals with autism spectrum disorder (ASD) and intellectual disabili
16 eral neurodevelopmental disorders, including autism spectrum disorder (ASD) and intellectual disabili
17 been noted consistently in individuals with autism spectrum disorder (ASD) and their families, inclu
18 genomes from 1,902 individuals affected with autism spectrum disorder (ASD) and their unaffected sibl
19 riched for genes implicated in non-syndromic autism spectrum disorder (ASD) and were differentially e
20 quences of approximately 8,000 children with autism spectrum disorder (ASD) and/or attention deficit
24 al motion (BM) and its putative anomalies in autism spectrum disorder (ASD) are not completely clarif
25 s of sociality in individuals diagnosed with autism spectrum disorder (ASD) are standardly explained
26 f the brain have been previously reported in autism spectrum disorder (ASD) but these alterations are
28 n in neural suppression in young adults with autism spectrum disorder (ASD) compared to neurotypical
32 ASD.SIGNIFICANCE STATEMENT Individuals with autism spectrum disorder (ASD) exhibit atypical attentio
34 e hypothesized link between gut bacteria and autism spectrum disorder (ASD) has been explored through
39 range of dysregulation of gene expression in autism spectrum disorder (ASD) have been reported, the r
41 r ex vivo histological postmortem studies of autism spectrum disorder (ASD) have shown gray matter mi
42 ting has been hypothesized to play a role in autism spectrum disorder (ASD) in an attempt to explain
44 ombined previously distinct subcategories of autism spectrum disorder (ASD) into a single diagnostic
57 and treatment of ASD.SIGNIFICANCE STATEMENT Autism spectrum disorder (ASD) is a neurodevelopmental p
73 g technology to evaluate the degree to which autism spectrum disorder (ASD) is related to reduced res
79 nditions with etiological heterogeneity like Autism Spectrum Disorder (ASD) often pose a challenge fo
81 seen in minimally-verbal (MV) children with Autism Spectrum Disorder (ASD) relates to deficits in co
83 aracterize their diagnoses, individuals with autism spectrum disorder (ASD) show enhanced performance
85 The association between macrocephaly and autism spectrum disorder (ASD) suggests that the mechani
87 are core features in schizophrenia (SZ) and autism spectrum disorder (ASD) that have been linked to
89 resent the largest exome sequencing study of autism spectrum disorder (ASD) to date (n = 35,584 total
91 esents particular challenges for youths with autism spectrum disorder (ASD) who often struggle to beh
92 tations in PTEN account for ~10% of cases of autism spectrum disorder (ASD) with coincident macroceph
93 The identification of an early biomarker for autism spectrum disorder (ASD) would improve the determi
94 omes of families containing individuals with autism spectrum disorder (ASD)(2,3) and population contr
95 ability, is the leading monogenetic cause of autism spectrum disorder (ASD), a neurodevelopmental con
96 ion in neuropsychiatric conditions including autism spectrum disorder (ASD), a neurodevelopmental syn
98 b are associated with X-linked macrocephaly, autism spectrum disorder (ASD), and intellectual disabil
99 key phenotypes in individuals diagnosed with autism spectrum disorder (ASD), and may potentially cont
100 ntion deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and obsessive-compulsive
101 s frequently disrupted in male subjects with autism spectrum disorder (ASD), but the functional conse
103 urrently known about sleep in the context of autism spectrum disorder (ASD), including ASD-related co
104 ifferent neuropsychiatric diseases including Autism Spectrum Disorder (ASD), intellectual disabilitie
105 oduplications of 16p11.2 are associated with autism spectrum disorder (ASD), intellectual disability
107 he effects of oxytocin on social deficits in autism spectrum disorder (ASD), no large-scale study has
109 SIB) is among the most dangerous concerns in autism spectrum disorder (ASD), often requiring detailed
110 d neurodevelopmental abnormalities including autism spectrum disorder (ASD), Rett syndrome-like featu
111 Number Variants (CNVs) confer high risk for Autism Spectrum Disorder (ASD), schizophrenia (SZ), and
112 aling, are prone to developing macrocephaly, autism spectrum disorder (ASD), seizures and intellectua
113 al environmental risk factor contributing to autism spectrum disorder (ASD), which compromises fetal
114 rived neurons are increasingly used to model Autism Spectrum Disorder (ASD), which is clinically and
153 renia (N = 696), bipolar disorder (N = 211), autism spectrum disorder (N = 126), or major depressive
154 sessions of videogame play in 39 youth with autism spectrum disorder and 23 age-matched youth with t
156 unced for childhood-onset disorders, such as autism spectrum disorder and attention-deficit/hyperacti
158 from two related neuropsychiatric disorders-autism spectrum disorder and bipolar disorder-to show th
159 y gamma oscillations, was equivalent between autism spectrum disorder and control groups, but importa
160 nalysis of de novo variants in patients with autism spectrum disorder and intellectual disability or
161 re repeatedly identified as risk factors for autism spectrum disorder and intellectual disability, bu
162 enuated by missense variants associated with autism spectrum disorder and intellectual disability.
163 tent of brain tissue in Alzheimer's disease, autism spectrum disorder and multiple sclerosis is signi
165 r diverse developmental phenotypes including autism spectrum disorder and other neurodevelopmental di
166 he behavioural phenotypes, that characterize autism spectrum disorder and Phelan-McDermid syndrome.
172 body movement is a distinguishing feature in autism spectrum disorder and that movement atypicalities
174 2-week clinical phase 2 study in adults with autism spectrum disorder balovaptan demonstrated improve
175 pothesis that aberrant sensory processing in autism spectrum disorder could be linked to atypical int
176 dy movement may distinguish individuals with autism spectrum disorder from individuals with typical d
179 and repeated administration of oxytocin for autism spectrum disorder have led researchers to hypothe
180 surrogates of social behavior in adults with autism spectrum disorder in an exploratory proof-of-mech
182 lted in a behavioral phenotype suggestive of autism spectrum disorder in the xCT(-/-) mice; in tests
183 ndary microcephaly in two other children and autism spectrum disorder in three previously healthy chi
190 nd that schizophrenia, bipolar disorder, and autism spectrum disorder share similar white matter micr
192 e had no immediate treatment effect on early autism spectrum disorder symptoms, the quality of parent
193 any anxiety disorder (OR 2.9, 1.2-6.7), and autism spectrum disorder traits (OR 44.1, 15.3-127.5) wa
194 dividuals with autism spectrum disorder, and autism spectrum disorder traits in individuals with ADHD
195 pplication to heterogenous disorders such as autism spectrum disorder will require individual-subject
196 , objective, and quantitative measurement of autism spectrum disorder's core symptoms are lacking, ma
197 s that ADHD traits occur in individuals with autism spectrum disorder, and autism spectrum disorder t
198 evelopmental delay, intellectual disability, autism spectrum disorder, and behavioral abnormalities a
201 risk factor for global developmental delay, autism spectrum disorder, and epileptic encephalopathy.
202 risk factor for global developmental delay, autism spectrum disorder, and epileptic encephalopathy.
203 highly penetrant, monogenic risk factor for autism spectrum disorder, and is a cause of Phelan-McDer
204 intellectual disability/developmental delay, autism spectrum disorder, and multiple medical comorbidi
206 a, attention-deficit hyperactivity disorder, autism spectrum disorder, anxiety disorders, seizures an
207 he central nervous system or associated with autism spectrum disorder, as well as 773 genes under unu
208 neuropsychiatric disorders [e.g., increased autism spectrum disorder, attention deficit hyperactivit
209 ntion deficit hyperactivity disorder (ADHD), autism spectrum disorder, bipolar disorder, major depres
210 athology of psychiatric disorders, including autism spectrum disorder, bipolar disorder, major depres
211 ng the inherited intellectual disability and autism spectrum disorder, fragile X syndrome (FXS).
212 Neurodevelopmental disorders, including autism spectrum disorder, have complex polygenic etiolog
213 xiety and mood disorders, schizophrenia, and autism spectrum disorder, in which they have been identi
214 e of neurodevelopmental disorders, including autism spectrum disorder, intellectual disability, and e
215 r, attention-deficit/hyperactivity disorder, autism spectrum disorder, intelligence, and educational
216 or depressive disorder, depressive symptoms, autism spectrum disorder, psychosis, and alcohol use dis
217 ric, and neurodegenerative disorders such as autism spectrum disorder, schizophrenia, and Huntington'
218 erived from RNA-sequencing studies including autism spectrum disorder, schizophrenia, and Zika virus
219 in our cohort were intellectual disability, autism spectrum disorder, seizures, variable brain malfo
243 morbidity maps of a cohort of children with autism spectrum disorder/intellectual disability versus
244 ivo Perturb-Seq, to functionally evaluate 35 autism spectrum disorder/neurodevelopmental delay (ASD/N
249 antibodies contributes to the development of autism spectrum disorders (ASD) has been entertained for
253 adsorption, is one of the possible causes of autism spectrum disorders (ASD) predominantly in patient
255 and debilitating symptom in individuals with autism spectrum disorders (ASD), but the neural basis un
256 tivate negative translation regulators cause autism spectrum disorders (ASD), which predominantly aff
257 ial symptoms following oxytocin treatment in autism spectrum disorders (ASD), while others point to e
261 uli were presented to adult individuals with autism spectrum disorders (ASD; n = 24, mean age 23 year
262 at PLR response was altered in children with autism spectrum disorders (ASDs) and other neurological
264 Taok2-dependent ASDs.SIGNIFICANCE STATEMENT Autism spectrum disorders (ASDs) are linked to abnormal
266 cation of genetic biomarkers associated with autism spectrum disorders (ASDs) could improve recurrenc
269 A major challenge facing the genetics of autism spectrum disorders (ASDs) is the large and growin
270 major hallmark of fragile X syndrome (FXS), autism spectrum disorders (ASDs), and other intellectual
271 elopmental defects.SIGNIFICANCE STATEMENT In autism spectrum disorders (ASDs), prenatal infection or
273 ebellar dysfunction has been demonstrated in autism spectrum disorders (ASDs); however, the circuits
274 ng variants in MINT2 have been identified in autism spectrum disorders (ASDs); however, these rare va
275 ocial interaction (SI) are a core symptom of autism spectrum disorders (ASDs); however, treatments fo
277 chizophrenia, obsessive-compulsive disorder, autism spectrum disorders and even personality disorders
278 tions in Shank3 are strongly associated with autism spectrum disorders and neural circuit changes in
285 ental challenge in developing treatments for autism spectrum disorders is the heterogeneity of the co
286 d that mosaicism quantification can stratify autism spectrum disorders recurrence risk due to de novo
287 s of neurodevelopmental disorders, including autism spectrum disorders, intellectual disabilities, an
288 a model of synaptic dysfunction relevant to autism spectrum disorders, were highly replicable across
295 ty, macrocephaly, and psychiatric disorders (autism spectrum disorders/attention deficit hyperactivit
297 Furthermore, the genetic interaction with autism-spectrum genes, such as ASH1L, DYRK1A, MED13, and
298 gender and thalamic GABA/Water in predicting Autism-Spectrum Quotient (AQ) and Ritvo Autism Asperger'
299 ts were selected based on their score on the Autism-Spectrum Quotient (AQ), and AQ scores were assess